
Sign up to save your podcasts
Or


We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
By Sensible Medicine Authors and Editors4.9
135135 ratings
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease

32,231 Listeners

4,269 Listeners

1,876 Listeners

543 Listeners

501 Listeners

904 Listeners

2,460 Listeners

3,382 Listeners

1,142 Listeners

8,010 Listeners

755 Listeners

521 Listeners

739 Listeners

441 Listeners

8,460 Listeners